Literature DB >> 31154406

GRAPPA 2018 Project Report.

Niti Goel1,2, Oliver FitzGerald3,4, Dafna D Gladman3,4, Philip S Helliwell3,4, Arthur Kavanaugh3,4, Walter P Maksymowych3,4, Philip J Mease3,4, Christopher T Ritchlin3,4, Laura C Coates3,4.   

Abstract

At the 2018 annual meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA), members received updates on several ongoing efforts. Among them were updates on GRAPPA's patient research partners; educational initiatives; research efforts, including the trainee symposium, pilot research grants, and Collaborative Research Network; treatment recommendations; and additional efforts related to advancing the understanding of disease aspects.

Entities:  

Keywords:  EDUCATION; GRAPPA; PSORIASIS; PSORIATIC ARTHRITIS; RESEARCH

Year:  2019        PMID： 31154406     DOI： 10.3899/jrheum.190121

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN： 0380-0903


  3 in total

1.  Efficacy of tofacitinib in reduction of inflammation detected on MRI in patients with Psoriatic ArthritiS presenTing with axial involvement (PASTOR): protocol of a randomised, double-blind, placebo-controlled, multicentre trial.

Authors:  Fabian Proft; Murat Torgutalp; Burkhard Muche; Valeria Rios Rodriguez; Maryna Verba; Denis Poddubnyy
Journal:  BMJ Open       Date:  2021-11-16       Impact factor: 2.692

2.  Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naïve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trials.

Authors:  Philip S Helliwell; Dafna D Gladman; Soumya D Chakravarty; Shelly Kafka; Chetan S Karyekar; Yin You; Kim Campbell; Kristen Sweet; Arthur Kavanaugh; Lianne S Gensler
Journal:  RMD Open       Date:  2020-02

3.  Conducting research in psoriatic arthritis: the emerging role of patient research partners.

Authors:  Niti Goel
Journal:  Rheumatology (Oxford)       Date:  2020-03-01       Impact factor: 7.580
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.